Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:1705-1712, 2006
DOI: 10.2337/db05-1640
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v56,p897)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimomura, K.
Right arrow Articles by Ashcroft, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimomura, K.
Right arrow Articles by Ashcroft, F. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mutations at the Same Residue (R50) of Kir6.2 (KCNJ11) That Cause Neonatal Diabetes Produce Different Functional Effects

Kenju Shimomura1, Christophe A.J. Girard1, Peter Proks1, Joanna Nazim2, Jonathan D. Lippiat1, Franco Cerutti3, Renata Lorini4, Sian Ellard5, Andrew T. Hattersley5, Fabrizio Barbetti6,7, and Frances M. Ashcroft1

1 University Laboratory of Physiology, Oxford University, Oxford, U.K
2 Department of Pediatric Endocrinology, Polish-American Children’s Hospital, Krakow, Poland
3 Department of Pediatrics, University of Turin, Turin, Italy
4 Department of Pediatrics, University of Genoa, Istituto di Ricovero e Cura a Carattere Scientifico G. Gaslini Institute, Genoa, Italy
5 Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, U.K
6 Ospedale Pediatrico Bambino Gesù, Rome, Italy
7 San Raffaele Biomedical Park Foundation, Rome, Italy

Address correspondence and reprint requests to Prof. Frances Ashcroft, University Laboratory of Physiology, Parks Road, Oxford OX1 3PT, U.K. E-mail: frances.ashcroft{at}physiol.ox.ac.uk

Abbreviations: [ATP]i, intracellular ATP concentration; hetR50P, heterozygous R50P; hetR50Q, heterozygous R50Q; homR50P, homomeric R50P; homR50Q, homomeric R50Q; IC50, half-maximal inhibitory concentration; KATP channel, ATP-sensitive K+ channel; PNDM, permanent neonatal diabetes; SUR, sulfonylurea receptor

Heterozygous mutations in the human Kir6.2 gene (KCNJ11), the pore-forming subunit of the ATP-sensitive K+ channel (KATP channel), are a common cause of neonatal diabetes. We identified a novel KCNJ11 mutation, R50Q, that causes permanent neonatal diabetes (PNDM) without neurological problems. We investigated the functional effects this mutation and another at the same residue (R50P) that led to PNDM in association with developmental delay. Wild-type or mutant Kir6.2/SUR1 channels were examined by heterologous expression in Xenopus oocytes. Both mutations increased resting whole-cell currents through homomeric and heterozygous KATP channels by reducing channel inhibition by ATP, an effect that was larger in the presence of Mg2+. However the magnitude of the reduction in ATP sensitivity (and the increase in the whole-cell current) was substantially larger for the R50P mutation. This is consistent with the more severe phenotype. Single–R50P channel kinetics (in the absence of ATP) did not differ from wild type, indicating that the mutation primarily affects ATP binding and/or transduction. This supports the idea that R50 lies in the ATP-binding site of Kir6.2. The sulfonylurea tolbutamide blocked heterozygous R50Q (89%) and R50P (84%) channels only slightly less than wild-type channels (98%), suggesting that sulfonylurea therapy may be of benefit for patients with either mutation.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. M. Ashcroft
ATP-sensitive K+ channels and disease: from molecule to malady
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E880 - E889.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Proks, K. Shimomura, T. J. Craig, C. A.J. Girard, and F. M. Ashcroft
Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome
Hum. Mol. Genet., August 15, 2007; 16(16): 2011 - 2019.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Masia, J. C. Koster, S. Tumini, F. Chiarelli, C. Colombo, C. G. Nichols, and F. Barbetti
An ATP-Binding Mutation (G334D) in KCNJ11 Is Associated With a Sulfonylurea-Insensitive Form of Developmental Delay, Epilepsy, and Neonatal Diabetes
Diabetes, February 1, 2007; 56(2): 328 - 336.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. I. Tarasov, H. J. Welters, S. Senkel, G. U. Ryffel, A. T. Hattersley, N. G. Morgan, and F. M. Ashcroft
A Kir6.2 Mutation Causing Neonatal Diabetes Impairs Electrical Activity and Insulin Secretion From INS-1 {beta}-Cells
Diabetes, November 1, 2006; 55(11): 3075 - 3082.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.